Filing Details

Accession Number:
0000899243-18-002327
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-01-30 20:58:08
Reporting Period:
2018-01-26
Accepted Time:
2018-01-30 20:58:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1609809 Seres Therapeutics Inc. MCRB () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1233684 N David Cook C/o Seres Therapeutics, Inc.
200 Sidney Street
Cambridge MA 02139
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-01-26 5,000 $0.00 141,673 No 4 M Direct
Common Stock Disposition 2018-01-26 1,738 $11.02 139,935 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock RESTRICTED STOCK UNITS Disposition 2018-01-26 5,000 $0.00 5,000 $0.00
Common Stock STOCK OPTION (RIGHT TO BUY) Disposition 2018-01-30 75,000 $0.00 75,000 $10.42
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,000 No 4 M Direct
75,000 2028-01-29 No 4 A Direct
Footnotes
  1. Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
  2. These restricted stock units have vested and settled or will vest and settle as to 20% of the restricted stock units on January 26, 2018, 30% on January 26, 2019; and 50% on January 26, 2020.
  3. The Option will vest as to 25% of the shares on January 30, 2019. The remainder of the shares will vest in 12 equal quarterly installments thereafter.